ACRS
Aclaris Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website aclaristx.com
- Employees(FY) 100
- ISIN US00461U1051
Performance
-2.86%
1W
-2.46%
1M
-0.0%
3M
+34.43%
6M
+13.33%
YTD
-85.68%
1Y
Profile
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment offers laboratory services. The company develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. It develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an oral MK2 inhibitor for the treatment of pancreatic and metastatic breast cancer. Aclaris Therapeutics, Inc. was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.
Technical Analysis of ACRS 2024-05-10
Overview:
In analyzing the technical indicators for ACRS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-08 00:06
- 2024-05-07 19:43
Q1 2024 Aclaris Therapeutics Inc Earnings Call(Yahoo Finance)
- 2024-05-07 16:06
- 2024-05-07 10:56
- 2024-05-07 05:15
- 2024-05-07 04:11
Aclaris: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-07 04:01
- 2024-04-29 19:00
- 2024-04-22 20:00
- 2024-04-04 21:40
- 2024-03-19 21:40
- 2024-03-13 20:45
- 2024-03-03 23:00
- 2024-03-03 20:40
- 2024-02-26 20:35
- 2024-02-26 19:38
Aclaris: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-02-26 18:00
- 2024-02-14 21:00
- 2024-02-12 20:40
- 2024-01-16 22:14
Aclaris (ACRS) Stock Rises on Appointment of New Interim CEO(Yahoo Finance)
- 2024-01-15 18:00
- 2024-01-09 18:00
- 2024-01-03 20:40
- 2023-12-19 03:01
Aclaris Therapeutics Provides Corporate Update(Globenewswire)
- 2023-12-05 03:01
- 2023-12-03 20:35
- 2023-11-15 20:35
- 2023-11-13 21:57
Aclaris (ACRS) Lead Drug Fails Rheumatoid Arthritis Study(Yahoo Finance)
- 2023-11-12 18:17
- 2023-11-12 18:06
Page 1 of 4
previousnext